“This is too important to be handled in such a sloppy fashion,” Dr. Nissen said. Dr. Michele Barry, a global health expert at Stanford University, said she had faith in Dr. Fauci’s assessment. Still, she added, “It is unusual to call a drug the ‘standard of care’ until peer review of data and publication, and before studies have shown benefit in mortality.”

Source: New York Times April 29, 2020 13:43 UTC